International studies have shown that elite athletes have a high prevalence of respiratory
symptoms and asthma as compared to normal subjects. It is unclear whether the increased
prevalence of asthma in elite athletes reflects "traditional asthma" or whether it is a
special form of "sports asthma". The treatment of elite athletes with asthma seems to vary
widely, and only a few studies have focused on the treatment of elite athletes with asthma.
Further knowledge of the pathogenesis of sports asthma would lead to a greater understanding
and better treatment of the condition. This study will investigate the type of airway
inflammation in elite athletes and examine the effect of treatment with inhaled steroids in
combination with long-acting beta-agonists versus placebo in the same group.
Phase:
Phase 4
Details
Lead Sponsor:
Bispebjerg Hospital
Collaborators:
Anti Doping Danmark GlaxoSmithKline Imperial College London Ragnhild Ibsens Legat For Medicinsk Forskning The Research Foundation of Bispebjerg Hospital
Treatments:
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination